EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?

Eva de Berranger iD, Anne-Flore Derache, Nassima Ramdane, Julien Labreuche, Pauline Navarin, Fanny Gonzales, Wadih Abou-Chahla, Brigitte Nelken iD, Bénédicte Bruno

Cancer Reports · 2024

DOI: 10.1002/cnr2.70015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Eva de Berranger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Hematology, Lille, France. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Acyclovir, Antiviral Agents, Transplantation, Homologous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acyclovir treatment is an efficient prophylaxis to prevent varicella‐zoster virus (VZV) reactivation after allogeneic hematopoietic stem cell transplantation (HSCT).

Aims

This single center retrospective study tried to determine if the lymphocytes immunophenotyping could help to determine the duration of prophylaxis, and evaluated complications, and associated risk factors for VZV infection. Methods and Results Eighty‐four children underwent an allogeneic HSCT, in which 77 received an acyclovir prophylaxis. Twenty‐one of the 77 had a VZV infection with an incidence rate of 1.30 per 100 patients‐months (exact 95% CI, 0.81 to 2.01). Among these 21 patients with VZV infection, 16 had an infection after withdrawing acyclovir prophylaxis within a median of 49 days (range, 11 days–5.8 months). Thirty‐five percent of the VZV infected patients were hospitalized, 9% had a visceral dissemination, and 9% had postherpetic neuralgia. In multivariate analysis, higher VZV infection rate was associated with conditioning regimen with total body irradiation, immunoglobulin substitution, and antithymocyte globulin. The incidence of VZV infection increased significantly when patients had a CD4+ lymphocytes count below 23% (cHR 3.28 [95% CI, 1.09–9.81]; p = 0.03) or a CD4 + /CD8 + ratio less than 0.9 (cHR 3.13 [95% CI, 1.04–9.36]; p = 0.04) at the time of stopping acyclovir prophylaxis.

Conclusion

After cessation of acyclovir prophylaxis, VZV reactivation can occur and be responsible for morbidity after allogeneic HSCT. This study suggests that the proportion of CD4+ lymphocytes and the CD4 + /CD8 + ratio can inform decisions about the duration of acyclovir prophylaxis after allogeneic HSCT to prevent VZV reactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationAcyclovirAntiviral AgentsTransplantation, HomologousHerpesvirus 3, HumanHumansMaleFemaleChildChild, PreschoolRetrospective StudiesAdolescentInfantVaricella Zoster Virus InfectionVirus ActivationRisk FactorsTransplantation ConditioningIncidence

Stichwörter der Autor:innen

VZV infectionacyclovir prophylaxisallogeneic hematopoietic stem cell transplantationchildrenherpes zosterlymphocytes immunophenotyping

Substanzen

AcyclovirAntiviral Agents

Autor:innen und Institutionen

  • Paediatric Hematology, Lille, France.
  • Department of Biostatistics, Lille, France.

ORCID-Profile: Eva de Berranger, Brigitte Nelken

Zitieren

APA

de Berranger, E., Derache, A. F., Ramdane, N., Labreuche, J., Navarin, P., Gonzales, F., Abou-Chahla, W., Nelken, B., & Bruno, B. (2024). VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?. Cancer Reports. https://doi.org/10.1002/cnr2.70015

Vancouver

de Berranger E, Derache AF, Ramdane N, Labreuche J, Navarin P, Gonzales F, et al. VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?. Cancer Reports. 2024. doi:10.1002/cnr2.70015

BibTeX
@article{deBerranger2024,
  author = {de Berranger, Eva and Derache, Anne-Flore and Ramdane, Nassima and Labreuche, Julien and Navarin, Pauline and Gonzales, Fanny and Abou-Chahla, Wadih and Nelken, Brigitte and Bruno, Bénédicte},
  title = {VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.70015}
}
Kostenlos starten →